Leading brokers name 3 ASX shares to buy

As brokers are taking a well-earned break after a busy year, I thought I would take a look at a few recommendations from last week that slipped under the radar.

Three which have been given buy ratings are listed below:

Japara Healthcare Ltd (ASX: JHC)

According to a note out of the Macquarie equities desk, the broker has an outperform rating and $2.25 price target on this aged care provider’s shares. The broker retained its positive rating despite Japara recently advising that first-half earnings are expected to be lower due to a fall in occupancy levels. While this led to Macquarie downgrading its forecasts, it still sees enough value to recommend it as a buy. I would agree with Macquarie on this one and believe it could be a great buy and hold investment due to Australia’s ageing population.

Volpara Health Technologies Ltd (ASX: VHT)

Analysts at Morgans have retained their add rating and 81 cents price target on this digital health solutions provider following the release of its recent trading update. The broker appears confident that Volpara will achieve revenue growth in excess of 200% in FY 2018 and is pleased to see existing contracts being renewed. I think Morgans is spot on with this one and Volpara would be a good addition at the current share price.

Webjet Limited (ASX: WEB)

A note out of UBS reveals that its analysts have upgraded the online travel agent’s shares to a buy rating with an increased price target of $12.60. The broker has made the move on the belief that the company’s core business-to-consumer business will continue to benefit from the shift to online booking. Furthermore, UBS feels a recent sell-off of its shares was overdone, leaving them trading at an attractive level. I agree with UBS and believe that Webjet is a buy at the current share price.

Lastly, here are three more shares that I believe ought to be classed as buys.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of VOLPARA FPO NZ. The Motley Fool Australia has recommended Webjet Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.